# Maravai Lifesciences Holdings, Inc.: filings

MRVI · Nasdaq · CIK 1823239 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mrvi.md) · [Financials](/companies/mrvi/financials.md) · [Filings](/companies/mrvi/filings.md) · [Insiders](/companies/mrvi/insiders.md)

## Reports and events: 90 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 193, 8-K 55, 3 26, SC 13G/A 22, 10-Q 17, CORRESP 13, UPLOAD 12, SC 13G 11, SCHEDULE 13G/A 9, 144 7, 10-K 6, DEF 14A 6, SCHEDULE 13G 5, 4/A 4, ARS 4, 424B4 3, DRS 3, EFFECT 3, S-1 3, S-1/A 3, DRS/A 2, DRSLTR 2, S-1MEF 2, S-8 2, 5 1, 8-A12B 1, CERT 1, DEFA14A 1, NT 10-K 1, PRE 14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 20:03 ET | [10-Q](/filings/0001823239-26-000059.md) | Quarterly report, period 2026-06-30 | 0001823239-26-000059 |
| 2026-08-06 | 20:05 ET | [8-K](/filings/0001823239-26-000056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-26-000056 |
| 2026-06-03 | 12:31 ET | [8-K](/filings/0001823239-26-000049.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001823239-26-000049 |
| 2026-05-29 | 20:19 ET | [8-K](/filings/0001823239-26-000046.md) | 5.07 Shareholder vote results | 0001823239-26-000046 |
| 2026-05-08 | 20:30 ET | [10-Q](/filings/0001823239-26-000024.md) | Quarterly report, period 2026-03-31 | 0001823239-26-000024 |
| 2026-05-07 | 20:05 ET | [8-K](/filings/0001823239-26-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-26-000022 |
| 2026-04-24 | 20:29 ET | [DEF 14A](/filings/0001823239-26-000014.md) | Proxy statement, period 2026-05-26 | 0001823239-26-000014 |
| 2026-02-26 | 21:06 ET | [10-K](/filings/0001823239-26-000011.md) | Annual report, period 2025-12-31 | 0001823239-26-000011 |
| 2026-02-25 | 21:05 ET | [8-K](/filings/0001823239-26-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-26-000005 |
| 2025-11-07 | 21:21 ET | [10-Q](/filings/0001823239-25-000120.md) | Quarterly report, period 2025-09-30 | 0001823239-25-000120 |
| 2025-11-06 | 21:03 ET | [8-K](/filings/0001823239-25-000117.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-25-000117 |
| 2025-10-27 | 20:23 ET | [8-K](/filings/0001823239-25-000113.md) | 5.02 Departure or appointment of officers or directors | 0001823239-25-000113 |
| 2025-08-11 | 21:02 ET | [10-Q](/filings/0001823239-25-000107.md) | Quarterly report, period 2025-06-30 | 0001823239-25-000107 |
| 2025-08-11 | 20:06 ET | [8-K](/filings/0001823239-25-000105.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001823239-25-000105 |
| 2025-07-18 | 20:45 ET | [8-K](/filings/0001823239-25-000099.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001823239-25-000099 |
| 2025-06-25 | 20:13 ET | [8-K](/filings/0001193125-25-146905.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-146905 |
| 2025-06-09 | 12:40 ET | [8-K](/filings/0001193125-25-137478.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-137478 |
| 2025-05-28 | 21:26 ET | [8-K](/filings/0001823239-25-000065.md) | 5.07 Shareholder vote results | 0001823239-25-000065 |
| 2025-05-12 | 20:28 ET | [10-Q](/filings/0001823239-25-000063.md) | Quarterly report, period 2025-03-31 | 0001823239-25-000063 |
| 2025-05-12 | 20:08 ET | [8-K](/filings/0001823239-25-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-25-000062 |
| 2025-04-18 | 20:06 ET | [DEF 14A](/filings/0001193125-25-085761.md) | Proxy statement, period 2025-05-22 | 0001193125-25-085761 |
| 2025-03-20 | 20:34 ET | [8-K](/filings/0001823239-25-000059.md) | 7.01 Regulation FD disclosure | 0001823239-25-000059 |
| 2025-03-18 | 20:09 ET | [10-K](/filings/0001823239-25-000034.md) | Annual report, period 2024-12-31 | 0001823239-25-000034 |
| 2025-03-18 | 20:08 ET | [8-K](/filings/0001823239-25-000033.md) | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001823239-25-000033 |
| 2025-02-25 | 01:43 ET | [8-K](/filings/0001823239-25-000028.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001823239-25-000028 |
| 2025-01-08 | 21:12 ET | [8-K](/filings/0001823239-25-000002.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001823239-25-000002 |
| 2024-12-18 | 21:35 ET | [8-K](/filings/0001823239-24-000133.md) | 8.01 Other events | 0001823239-24-000133 |
| 2024-12-05 | 21:07 ET | [8-K](/filings/0001823239-24-000124.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001823239-24-000124 |
| 2024-11-12 | 22:24 ET | [10-Q](/filings/0001823239-24-000118.md) | Quarterly report, period 2024-09-30 | 0001823239-24-000118 |
| 2024-11-07 | 21:04 ET | [8-K](/filings/0001823239-24-000105.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-24-000105 |
| 2024-09-12 | 19:58 ET | [8-K](/filings/0001823239-24-000100.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001823239-24-000100 |
| 2024-08-08 | 20:06 ET | [10-Q](/filings/0001823239-24-000095.md) | Quarterly report, period 2024-06-30 | 0001823239-24-000095 |
| 2024-08-07 | 20:06 ET | [8-K](/filings/0001823239-24-000093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-24-000093 |
| 2024-07-29 | 20:11 ET | [8-K](/filings/0001823239-24-000091.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001823239-24-000091 |
| 2024-06-12 | 22:23 ET | [8-K](/filings/0001823239-24-000084.md) | 5.02 Departure or appointment of officers or directors | 0001823239-24-000084 |
| 2024-05-28 | 21:19 ET | [8-K](/filings/0001823239-24-000082.md) | 5.07 Shareholder vote results | 0001823239-24-000082 |
| 2024-05-09 | 20:44 ET | [10-Q](/filings/0001823239-24-000060.md) | Quarterly report, period 2024-03-31 | 0001823239-24-000060 |
| 2024-05-08 | 20:09 ET | [8-K](/filings/0001823239-24-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-24-000058 |
| 2024-04-25 | 20:41 ET | [DEF 14A](/filings/0001193125-24-114058.md) | Proxy statement, period 2024-05-23 | 0001193125-24-114058 |
| 2024-02-29 | 22:05 ET | [10-K](/filings/0001823239-24-000032.md) | Annual report, period 2023-12-31 | 0001823239-24-000032 |
| 2024-02-22 | 21:08 ET | [8-K](/filings/0001823239-24-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-24-000028 |
| 2023-11-08 | 22:28 ET | [10-Q](/filings/0001823239-23-000089.md) | Quarterly report, period 2023-09-30 | 0001823239-23-000089 |
| 2023-11-07 | 21:11 ET | [8-K](/filings/0001823239-23-000087.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-23-000087 |
| 2023-08-08 | 20:20 ET | [10-Q](/filings/0001823239-23-000081.md) | Quarterly report, period 2023-06-30 | 0001823239-23-000081 |
| 2023-08-07 | 20:19 ET | [8-K](/filings/0001823239-23-000079.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-23-000079 |
| 2023-07-27 | 20:11 ET | [8-K](/filings/0001823239-23-000077.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001823239-23-000077 |
| 2023-07-20 | 20:08 ET | [8-K](/filings/0001823239-23-000072.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001823239-23-000072 |
| 2023-05-22 | 20:04 ET | [8-K](/filings/0001823239-23-000041.md) | 5.07 Shareholder vote results | 0001823239-23-000041 |
| 2023-05-09 | 21:10 ET | [10-Q](/filings/0001823239-23-000039.md) | Quarterly report, period 2023-03-31 | 0001823239-23-000039 |
| 2023-05-08 | 20:09 ET | [8-K](/filings/0001823239-23-000037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001823239-23-000037 |

Page 1 of 2. [Older](/companies/mrvi/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.